Trial Profile
A study to assess the efficacy and safety of recombinant human adenovirus p53 injection and radiotherapy for the treatment of advanced soft tissue sarcoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Contusugene ladenovec (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 02 Sep 2015 New trial record